From January 1, 2024 to March 31, 2024, the company has repurchased 310,912 shares, representing 0.23% for CNY 14.91 million. With this, the company has completed the repurchase of 607,326 shares, representing 0.45% for CNY 34.9 million under the buyback announced on November 13, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.99 CNY | -0.38% |
|
+15.82% | -57.60% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-57.60% | 540M | |
+20.12% | 127B | |
+25.25% | 117B | |
+25.56% | 27.77B | |
-19.51% | 20.44B | |
-14.36% | 16.62B | |
-15.63% | 15.92B | |
-46.67% | 14.94B | |
+11.89% | 14.74B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- 688202 Stock
- News Shanghai Medicilon Inc.
- Tranche Update on Shanghai Medicilon Inc.'s Equity Buyback Plan announced on November 13, 2023.